Showing results (811-820 of 990) with videos related to

Sort By:
Pageof 99
The Journal of Allergy and Clinical Immunology|August 19, 1999
IgE reactivity to Api g 1, a major celery allergen, in a Central European population is based on primary sensitization by Bet v 1K Hoffmann-Sommergruber, P Demoly, R Crameri, et al.
Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.
Aging Clinical and Experimental Research|June 22, 2020
Benefits of a 3-week outpatient balneotherapy programme on patient-reported outcomesP L Bernard, G Ninot, N Raffort, et al.
Allergy|July 24, 2009
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN studyJ Bousquet, C Bachert, G W Canonica, et al.
European Journal of Clinical Nutrition|February 27, 2014
Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)D J Costa, P Marteau, M Amouyal, et al.
The European Respiratory Journal|May 27, 2017
Absolute values of lung function explain the sex difference in breathlessness in the general populationMagnus Ekström, Linus Schiöler, Rune Grønseth, et al.
Allergy|April 11, 2008
Rupatadine in allergic rhinitis and chronic urticariaJ Mullol, J Bousquet, C Bachert, et al.
Allergy|January 14, 2018
The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adultsV Siroux, N Ballardini, M Soler, et al.
Allergy|December 7, 2007
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 updateJ L Brozek, C E Baena-Cagnani, S Bonini, et al.
Allergy|February 1, 2005
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATEM Humbert, R Beasley, J Ayres, et al.
Pageof 99